Bracun, Valentina
Aboumsallem, Joseph Pierre
van der Meer, Peter
de Boer, Rudolf A.
Funding for this research was provided by:
University of Groningen
Article History
First Online: 9 June 2020
Compliance with Ethical Standards
:
: Valentina Bracun declares that she has no conflict of interest. Joseph Pierre Aboumsallem declares that he has no conflict of interest. Peter van der Meer has received consultancy fees and/or research grants from Novartis, Servier, Vifor Pharma, Astra Zenica, Pfizer, and Ionis. Rudolf A. de Boer has received speaker’s honoraria from Abbott, AstraZeneca, Novartis, and Roche. Additionally, the University Medical Center Groningen, which employs Drs. de Boer and van der Meer, has received research grants and/or fees from AstraZeneca, Abbott, Bristol-Myers Squibb, Novartis, Novo Nordisk, and Roche.
: This article does not contain any studies with human or animal subjects performed by any of the authors.